$TMDX 3 SEC Filings

Filed On	Filing
29 Sep 2026	Form 3: Araujo Fernando N., See Remarks No securities owned
13 Mar 2026	Form 3: Forsyth Matthew S., See Remarks No securities owned
12 Feb 2026	Form 3: Cecere Giovanni, Chief Commercial Officer No securities owned
02 Dec 2024	Form 3: Hernandez Gerardo, Chief Financial Officer No securities owned
07 Jun 2023	Form 3: Ranganath Anil P., See Remarks No securities owned
02 Feb 2023	Form 3: Corcoran Nicholas, See Remarks No securities owned
06 Aug 2021	Form 3: Godhani Rakesh P., Chief Digital Officer No securities owned
24 Mar 2021	Form 3: Lovell Stephanie, Director No securities owned
05 Jan 2021	Form 3: Raines Merilee, Director No securities owned
07 Aug 2019	Form 3: Damme Laura, VP, Clinical Affairs No securities owned
01 May 2019	Form 3: Flagship Ventures Fund Iv General Partner Llc, 10% owner and 4 others Holds 214,285 shares of Common Stock
01 May 2019	Form 3: Abrams Capital MANAGEMENT, L.p., 10% owner and 6 others
01 May 2019	Form 3: Gordon Stephen, Chief Financial Officer Holds 28,571 shares of Common Stock
01 May 2019	Form 3: Sullivan John F, VP of Quality & Engineering Holds 9,428 shares of Common Stock
01 May 2019	Form 3: Carey John F, VP of Operations
01 May 2019	Form 3: Provost Miriam, VP of US Regulatory & FDA Rel.
01 May 2019	Form 3: Tobin James R, Director Holds 142,857 shares of Common Stock
01 May 2019	Form 3: Khayal Tamer I, Chief Commercial Officer Holds 44,776 shares of Common Stock
01 May 2019	Form 3: Gunderson Thomas James, Director
01 May 2019	Form 3: Weill David, Director

Comments